Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.
Press releases published on October 31, 2025
Refined Energy Corp. Announces Marketing Program
VANCOUVER, British Columbia, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Refined Energy Corp. (CSE: RUU | OTC: RRUUF | FRA: CWA0) ("Refined” or the "Company") is pleased to announce that it is undertaking a marketing program by engaging RMK Marketing Inc. (address: …
Aventis Energy Announces Closing of Flow-Through Financing
VANCOUVER, British Columbia, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Aventis Energy Inc. (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF), is pleased to announce the closing of its non-brokered private placement, announced October 21, 2025, for …
Amar Technolabs Group Achieves Milestones in Aviation Safety, Global Governance Training & IoT Solutions
AHMEDABAD, GUJARAT, INDIA, October 31, 2025 /EINPresswire.com/ -- Amar Technolabs Private Limited Group, a diversified global IT and technology solutions provider with a proven track record since 2009, proudly announces key achievements across its four …
Repayment of Senior Unsecured Non-Convertible Debentures
VANCOUVER, British Columbia, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (the “Company” or “Imperial”) (TSX:III) announces that it has fully repaid all outstanding senior unsecured non-convertible debentures due November 1, 2025 (the “ …
Skyharbour Announces Participation in Red Cloud's 2025 Fall Mining Showcase in Toronto
Vancouver, BC, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce that the Company will be presenting at Red Cloud’s Fall Mining Showcase 2025. The annual …
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from …
Cellectis to Report Third Quarter Financial Results on November 7, 2025
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced …
Global Helium Corp. Announces Completion of Plan of Arrangement and Go-Private Transaction
CALGARY, Alberta, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Global Helium Corp. ("Global" or the "Company") (CSE: HECO) and 2679158 Alberta Ltd. (the "Purchaser") announce today the closing of the previously announced acquisition of the Company by the Purchaser …
Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CANTON, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (the “Company”) (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound …
Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy
CHICAGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the initiation of a new research and development program …
NexGold Announces Closing of C$112.5 Million Bought Deal Private Placement of Units and Flow-Through Shares
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to announce that it has …
GoldHaven Resources Acquires Claims Within Magno Project
VANCOUVER, British Columbia, Oct. 31, 2025 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. (“GoldHaven” or the “Company”) (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) is pleased to announce that it has entered into an agreement to acquire the Hamel claims (the “ …
CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025
BERKELEY HEIGHTS, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it will …
Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy
Vancouver, Canada, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics to …
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and …
OROCO RESOURCE CORP. PROVIDES FINANCING UPDATE
VANCOUVER, Canada, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTCQB: ORRCF) confirms that the non-brokered private placement financing, announced on September 25, 2025, is proceeding as planned and will be completed within the …
Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong Kong
COPENHAGEN, Denmark, Oct. 31, 2025 (GLOBE NEWSWIRE) -- BOOST Pharma, a clinical-stage cell biotech company focused on rare skeletal pediatric diseases, is proud to announce that new long-term data from the first-in-class BOOSTB4 stem cell therapy trial has …